NCT02564692Enrolling by invitation
GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
Alzheimer's Prevention Registry GeneMatch Program
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
The purpose of the Alzheimer's Prevention Registry GeneMatch program is to identify a large group of people interested in participating in research studies or clinical trials based in part on their genetic background. This genetic information will be used to match interested individuals to studies, providing a recruitment resource to the Alzheimer's scientific community. Interested individuals should visit www.endALZnow.org/GeneMatch to join the GeneMatch program.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 500000 (estimated)
- First submitted
- 29 Sept 2015
- Start date
- 1 Nov 2015
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Banner Health
- Diseases
- Alzheimer disease
- NCT number
- NCT02564692
What you commit to
- Study type: Observational
- Planned participants: 500000
- From 1 Nov 2015 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Self-reported diagnosis of dementia or any other objective cognitive impairment syndrome
Other
- Unable to comply with this project's protocol requirements
Who the study is looking for
- Age 50-90, inclusive
- Provide basic demographic, medical history, and contact information
- Consent to APOE genotyping without receiving results
- Live in the United States
Age in the registry: 50 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Banner Alzheimer's Institute Coordinator of this site? Confirm its status | Phoenix | United States | Unknown status |
Related publications
- Learning about a heightened genetic risk for dementia: Expected stigma is greater than experienced stigma.Psychol Aging · 2026 · PMID 41729767
This page is information, not medical advice. Discuss any trial with your doctor.